Narcolepsy Market Report

Global and Region Narcolepsy Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：181
  • REPORT CODE：GMM949842
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Narcolepsy is a neurological disorder that affects the control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. These sudden sleep attacks may occur during any type of activity at any time of the day.

    People with narcolepsy can be substantially helped, but not cured. Treatment is tailored to the individual, based on symptoms and therapeutic response. The time required to achieve optimal control of symptoms is highly variable and may take several months or longer. Medication adjustments are frequently necessary, and complete control of symptoms is seldom possible. While oral medications are the mainstay of formal narcolepsy treatment, lifestyle changes are also important.

    The report details the trend, potential and market size of Narcolepsy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Narcolepsymarket, defines the market attractiveness level of Narcolepsy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Narcolepsy industry, describes the types of Narcolepsy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Narcolepsy market and the development prospects and opportunities of Narcolepsy industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Narcolepsy market in Chapter 13.

    By Player:

    • BIOPROJET (Paris)

    • Jazz Pharmaceuticals plc (Republic of Ireland)

    • Novartis AG (Switzerland)

    • Ligand Pharmaceuticals, Inc (US)

    • Mylan NV (US)

    • Shire (Republic of Ireland)

    • Arena Pharmaceuticals, Inc (US)

    • Shionogi Inc (US)

    • Teva Pharmaceutical Industries Ltd (Israel)

    • Graymark Healthcare, Inc (US)

    By Type:

    • Polysomnogram

    • Multiple Sleep Latency Test

    By End-User:

    • Hospitals

    • Retail Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Narcolepsy Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Narcolepsy Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Narcolepsy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Narcolepsy Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Narcolepsy Market Analysis and Outlook to 2022

    • 7.1 Global Narcolepsy Consumption (2017-2022)

    • 7.2 United States Narcolepsy Consumption (2017-2022)

    • 7.3 Europe Narcolepsy Consumption (2017-2022)

    • 7.4 China Narcolepsy Consumption (2017-2022)

    • 7.5 Japan Narcolepsy Consumption (2017-2022)

    • 7.6 India Narcolepsy Consumption (2017-2022)

    • 7.7 South Korea Narcolepsy Consumption (2017-2022)

    8 Region and Country-wise Narcolepsy Market Analysis and Outlook to 2028

    • 8.1 Global Narcolepsy Consumption Forecast (2022-2028)

    • 8.2 United States Narcolepsy Consumption Forecast (2022-2028)

    • 8.3 Europe Narcolepsy Consumption Forecast (2022-2028)

    • 8.4 China Narcolepsy Consumption Forecast (2022-2028)

    • 8.5 Japan Narcolepsy Consumption Forecast (2022-2028)

    • 8.6 India Narcolepsy Consumption Forecast (2022-2028)

    • 8.7 South Korea Narcolepsy Consumption Forecast (2022-2028)

    9 Global Narcolepsy Market Outlook by Types and Applications to 2022

    • 9.1 Global Narcolepsy Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Polysomnogram Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Multiple Sleep Latency Test Consumption and Growth Rate (2017-2022)

    • 9.2 Global Narcolepsy Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Narcolepsy Market Outlook by Types and Applications to 2028

    • 10.1 Global Narcolepsy Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Polysomnogram Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Multiple Sleep Latency Test Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Narcolepsy Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Narcolepsy Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Narcolepsy Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Narcolepsy Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Narcolepsy Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Narcolepsy Market Competitive Analysis

    • 14.1 BIOPROJET (Paris)

      • 14.1.1 BIOPROJET (Paris) Company Details

      • 14.1.2 BIOPROJET (Paris) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 BIOPROJET (Paris) Narcolepsy Product and Service

    • 14.2 Jazz Pharmaceuticals plc (Republic of Ireland)

      • 14.2.1 Jazz Pharmaceuticals plc (Republic of Ireland) Company Details

      • 14.2.2 Jazz Pharmaceuticals plc (Republic of Ireland) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Jazz Pharmaceuticals plc (Republic of Ireland) Narcolepsy Product and Service

    • 14.3 Novartis AG (Switzerland)

      • 14.3.1 Novartis AG (Switzerland) Company Details

      • 14.3.2 Novartis AG (Switzerland) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Novartis AG (Switzerland) Narcolepsy Product and Service

    • 14.4 Ligand Pharmaceuticals, Inc (US)

      • 14.4.1 Ligand Pharmaceuticals, Inc (US) Company Details

      • 14.4.2 Ligand Pharmaceuticals, Inc (US) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Ligand Pharmaceuticals, Inc (US) Narcolepsy Product and Service

    • 14.5 Mylan NV (US)

      • 14.5.1 Mylan NV (US) Company Details

      • 14.5.2 Mylan NV (US) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Mylan NV (US) Narcolepsy Product and Service

    • 14.6 Shire (Republic of Ireland)

      • 14.6.1 Shire (Republic of Ireland) Company Details

      • 14.6.2 Shire (Republic of Ireland) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Shire (Republic of Ireland) Narcolepsy Product and Service

    • 14.7 Arena Pharmaceuticals, Inc (US)

      • 14.7.1 Arena Pharmaceuticals, Inc (US) Company Details

      • 14.7.2 Arena Pharmaceuticals, Inc (US) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Arena Pharmaceuticals, Inc (US) Narcolepsy Product and Service

    • 14.8 Shionogi Inc (US)

      • 14.8.1 Shionogi Inc (US) Company Details

      • 14.8.2 Shionogi Inc (US) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Shionogi Inc (US) Narcolepsy Product and Service

    • 14.9 Teva Pharmaceutical Industries Ltd (Israel)

      • 14.9.1 Teva Pharmaceutical Industries Ltd (Israel) Company Details

      • 14.9.2 Teva Pharmaceutical Industries Ltd (Israel) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Teva Pharmaceutical Industries Ltd (Israel) Narcolepsy Product and Service

    • 14.10 Graymark Healthcare, Inc (US)

      • 14.10.1 Graymark Healthcare, Inc (US) Company Details

      • 14.10.2 Graymark Healthcare, Inc (US) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Graymark Healthcare, Inc (US) Narcolepsy Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Narcolepsy

    • Figure Narcolepsy Picture

    • Table Global Narcolepsy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Narcolepsy Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Narcolepsy Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Narcolepsy Consumption by Country (2017-2022)

    • Figure United States Narcolepsy Consumption and Growth Rate (2017-2022)

    • Table Europe Narcolepsy Consumption and Growth Rate (2017-2022)

    • Figure China Narcolepsy Consumption and Growth Rate (2017-2022)

    • Figure Japan Narcolepsy Consumption and Growth Rate (2017-2022)

    • Figure India Narcolepsy Consumption and Growth Rate (2017-2022)

    • Figure South Korea Narcolepsy Consumption and Growth Rate (2017-2022)

    • Figure Global Narcolepsy Consumption Forecast by Country (2022-2028)

    • Figure United States Narcolepsy Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Narcolepsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Narcolepsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Narcolepsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Narcolepsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Narcolepsy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Polysomnogram Consumption and Growth Rate (2017-2022)

    • Figure Global Multiple Sleep Latency Test Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Polysomnogram Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Multiple Sleep Latency Test Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Narcolepsy Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Narcolepsy Export by Region (Top 5 Countries) (2017-2028)

    • Table BIOPROJET (Paris) (Foundation Year, Company Profile and etc.)

    • Table BIOPROJET (Paris) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table BIOPROJET (Paris) Narcolepsy Product and Service

    • Table Jazz Pharmaceuticals plc (Republic of Ireland) (Foundation Year, Company Profile and etc.)

    • Table Jazz Pharmaceuticals plc (Republic of Ireland) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jazz Pharmaceuticals plc (Republic of Ireland) Narcolepsy Product and Service

    • Table Novartis AG (Switzerland) (Foundation Year, Company Profile and etc.)

    • Table Novartis AG (Switzerland) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG (Switzerland) Narcolepsy Product and Service

    • Table Ligand Pharmaceuticals, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Ligand Pharmaceuticals, Inc (US) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ligand Pharmaceuticals, Inc (US) Narcolepsy Product and Service

    • Table Mylan NV (US) (Foundation Year, Company Profile and etc.)

    • Table Mylan NV (US) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan NV (US) Narcolepsy Product and Service

    • Table Shire (Republic of Ireland) (Foundation Year, Company Profile and etc.)

    • Table Shire (Republic of Ireland) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire (Republic of Ireland) Narcolepsy Product and Service

    • Table Arena Pharmaceuticals, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Arena Pharmaceuticals, Inc (US) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arena Pharmaceuticals, Inc (US) Narcolepsy Product and Service

    • Table Shionogi Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Shionogi Inc (US) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shionogi Inc (US) Narcolepsy Product and Service

    • Table Teva Pharmaceutical Industries Ltd (Israel) (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd (Israel) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd (Israel) Narcolepsy Product and Service

    • Table Graymark Healthcare, Inc (US) (Foundation Year, Company Profile and etc.)

    • Table Graymark Healthcare, Inc (US) Narcolepsy Sales, Price, Value and Gross Profit (2017-2022)

    • Table Graymark Healthcare, Inc (US) Narcolepsy Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US